Alumni Ventures’ Emerging Markets Fund offers a portfolio of ~20-30 promising, venture-backed companies from emerging markets in the U.S. and internationally. It’s a chance to further diversify your portfolio, seeking opportunities in rapidly growing regions where there are outsized opportunities.
To learn more, click below to review fund materials or book a call with a Senior Partner.
In this recent white paper, we explore the trends, opportunities, and challenges of venture investing in international emerging markets. We postulate that emerging markets offer a promising venture investment opportunity of reasonable valuations, diversification across geographies, and leapfrogging into the world’s fastest-growing areas, both technologically and demographically.
In summary, we think the opportunity is profound. In fact, it’s the focus for Alumni Ventures’ new Emerging Markets Fund, where we will invest in a portfolio of ~20-30 deals from outside the typical three-point VC market of San Francisco, NYC, and Boston — both in the U.S. and abroad. Here we explore the markets region by region and then summarize the pros and cons of venture investing in emerging markets.
ABOUT THE AUTHOR
Krithika Kumar | Principal | Strawberry Creek Ventures
Krithika Kumar is a member of Strawberry Creek Ventures, where she brings experience in venture capital, entrepreneurship, and scientific research to the team. Krithika has led diligence and sourced deals as a Venture Partner at Humboldt Fund and a Senior Venture Fellow at Castor Ventures. Prior to venture capital, she co-founded a cognitive fitness company to enhance brain performance across the age spectrum. She also served as the Director of Business Development at Prime Biologics where she established strategic partnerships in the U.S., EU, and emerging markets. Krithika did her postdoctoral research studying the gut microbiome at Cornell University and has a Ph.D. in biological sciences from Texas A&M University.